Irawati Kandela

Irawati (Angki) Kandela has extensive work experience in the field of pharmaceuticals and biomedical research. Irawati (Angki)'smost recent role is as the Director of Translation Sciences and Project Management at Cour Pharmaceuticals Development Company, Inc. Irawati (Angki) joined the company in 2021 and is currently serving in this position.

Prior to that, Angki served as the Director of Operations at NeuroLux from 2020 to 2021. In this role, they were responsible for various tasks, including writing and submitting grant applications, managing finance and billing, organizing laboratory protocols, and ensuring the timely completion of manufacturing processes. Irawati (Angki) also provided support to customers and assisted with surgery challenges.

Before NeuroLux, Angki worked as a Consultant at O2M Technologies from 2019 to 2020.

From 2011 to 2019, Angki held the position of Assistant Director at Northwestern University. Irawati (Angki) played an instrumental role in the drug development process, collaborating with numerous investigators and securing external funding through grant writing. Irawati (Angki) also managed the business aspects of the department, including budgeting, accounting, and marketing.

Earlier in their career, Angki served as the Head of Biology at Cellectar Biosciences, Inc. from 2006 to 2011. In this role, they designed and organized preclinical oncology projects, managed a team, and developed proprietary compounds as tumor biomarkers.

Angki's career in research began as a Research Assistant at UW-Madison from 2002 to 2006, although specific details about their role during this time are not provided.

Irawati (Angki) Kandela has a strong education background in pharmaceutical sciences. Irawati (Angki) earned a Ph.D. in Pharmaceutical Sciences from the University of Wisconsin-Madison in 2006, after completing their MS in the same field at the same institution in 2002. Prior to their studies in the United States, they obtained their Pharmacy degree from Institut Teknologi Bandung in 1998, and their Bachelor of Science in Pharmacy from the same institution in 1997.

Additionally, Irawati (Angki) Kandela has obtained a certification in Tufts CSDD Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation from the Tufts Center for the Study of Drug Development in April 2022.